The Venture Codex Logo

The Venture Codex

ALSA Ventures

78 Pall Mall, London, Greater London, SW1Y 5ES, United Kingdom

Overview

International life science investor focused on novel therapeutics.

Founded

2019

Deals · 12mo

0

Links

WebsiteLinkedIn

Stage focus

Series A
Series B

Geographic focus

Spain
Switzerland
United Kingdom

Sector focus

—

Investment portfolio

4rounds
NAMEDATESIZE
ReproNovo
May 2025Participated
$65 MSeries A
Epsilogen
Sep 2024Participated
$16 MSeries B
Epsilogen
Mar 2022Participated
$41 MSeries B
Smartvel
Oct 2018Participated
$1 MOther Equity
ReproNovo
May 2025Participated
$65 MSeries A
Epsilogen
Sep 2024Participated
$16 MSeries B
Epsilogen
Mar 2022Participated
$41 MSeries B
Smartvel
Oct 2018Participated
$1 MOther Equity
4
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

ALSA Ventures: 4 funding rounds are recorded in the selected participation categories.All available history.
ALSA Ventures: 4 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A01
Series B02
Other Equity01

Monthly Deal Activity

ALSA Ventures: 4 deals are recorded across 97 months.All available history.
ALSA Ventures: 4 deals are recorded across 97 months. All available history
MonthDeals
Oct '181
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '221
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '241
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '251
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

ALSA Ventures: Health & Life Sciences is the largest displayed sector by deal count (3 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

ALSA Ventures: Health & Life Sciences is the largest displayed sector by deal count (3 deals). All available history
SectorDeals
Health & Life Sciences3
Travel & Hospitality1
Networks, Cloud & Communication1
Enterprise Software1
Media & Entertainment1
AI & Machine Learning1
Transportation & Logistics1

Deal Size Distribution

ALSA Ventures: 4 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

ALSA Ventures: 4 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M0
$10M-$25M1
$25M-$50M1
$50M-$100M1
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

ALSA Ventures: Europe has the largest recorded deal count among the displayed regions (4 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

ALSA Ventures: Europe has the largest recorded deal count among the displayed regions (4 deals). All available history
RegionDeals
Europe4
ALSA Ventures: 15 co-investors are shown, with 3B Future Health Fund sharing 2 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

ALSA Ventures: 15 co-investors are shown, with 3B Future Health Fund sharing 2 recorded deals. All available history
Co-investorShared deals
3B Future Health Fund2
British Patient Capital2
Epidarex Capital2
AXA IM Alts1
Caixa Capital Risc1
Caribou Property1
dRx Capital1
Faraday Venture Partners1
Fides Capital1
Jeito Capital1
M Ventures1
Novartis1
Pinama1
Schroders Capital1
Ysios Capital1

Investment Strategy

ALSA Ventures: Led accounts for 0% and participating for 100% of round participation.All available history.
ALSA Ventures: Led accounts for 0% and participating for 100% of round participation. All available history
CategoryDeals (count)Share (%)
Led00%
Participating4100%
ALSA Ventures: Single-lead accounts for 0% and co-led for 0% of lead dynamics.All available history.
ALSA Ventures: Single-lead accounts for 0% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led00%

Lead dynamics requires at least one led deal in this range

Team

Alek Safarian

CEO

Graeme Martin

Chief Investment Officer

Lorna Collings

Chief Financial Officer

Robert Balfour

Investment Director